GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +71.3% | +321.3% | +179.2% | +781.2% | – | |
| – | – | – | – | +173.5% | – | |
| – | – | – | +2,016.7% | – | – | |
| – | – | -1,629.4% | – | +309.2% | – | |
| – | +396.9% | +40.7% | -28.5% | +484.3% | -100.0% | |
| – | – | -327.1% | -55.7% | +695.8% | – | |
| – | – | -100.0% | – | – | – | |
| – | -125.8% | +0.0% | – | – | – | |
| – | +184.7% | +91.6% | +92.5% | -84.3% | – | |
| – | – | +47.3% | +143.0% | -338.7% | – | |
| – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.